Wealthsource Partners LLC Acquires Shares of 980 CIGNA Co. (CI)

Wealthsource Partners LLC acquired a new position in shares of CIGNA Co. (NYSE:CI) in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 980 shares of the health services provider’s stock, valued at approximately $204,000.

Several other institutional investors and hedge funds have also recently bought and sold shares of the company. Riverhead Capital Management LLC lifted its position in shares of CIGNA by 22.5% during the third quarter. Riverhead Capital Management LLC now owns 94,357 shares of the health services provider’s stock valued at $19,650,000 after purchasing an additional 17,310 shares in the last quarter. Ancora Advisors LLC bought a new position in shares of CIGNA during the third quarter valued at about $106,000. Standard Life Aberdeen plc lifted its position in shares of CIGNA by 4.1% during the third quarter. Standard Life Aberdeen plc now owns 197,704 shares of the health services provider’s stock valued at $41,172,000 after purchasing an additional 7,843 shares in the last quarter. Bridgeway Capital Management Inc. lifted its position in shares of CIGNA by 21.5% during the third quarter. Bridgeway Capital Management Inc. now owns 444,550 shares of the health services provider’s stock valued at $92,578,000 after purchasing an additional 78,600 shares in the last quarter. Finally, Richard Bernstein Advisors LLC bought a new position in shares of CIGNA during the third quarter valued at about $4,050,000. Institutional investors own 93.51% of the company’s stock.

CI has been the topic of a number of recent analyst reports. ValuEngine lowered shares of CIGNA from a “hold” rating to a “sell” rating in a research report on Monday, August 13th. Cowen initiated coverage on shares of CIGNA in a research report on Monday, September 17th. They set an “outperform” rating and a $240.00 price target on the stock. Credit Suisse Group raised their price target on shares of CIGNA from $223.00 to $237.00 and gave the company an “outperform” rating in a research report on Tuesday, September 18th. Leerink Swann raised their price target on shares of CIGNA from $235.00 to $250.00 and gave the company an “outperform” rating in a research report on Friday, September 21st. Finally, Cantor Fitzgerald initiated coverage on shares of CIGNA in a research report on Wednesday, September 26th. They set an “overweight” rating and a $245.00 price target on the stock. Three equities research analysts have rated the stock with a hold rating, eleven have given a buy rating and one has assigned a strong buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $236.29.

Shares of CI stock opened at $206.11 on Friday. The stock has a market capitalization of $52.19 billion, a price-to-earnings ratio of 19.70, a P/E/G ratio of 1.21 and a beta of 0.54. The company has a debt-to-equity ratio of 1.61, a quick ratio of 0.98 and a current ratio of 0.98. CIGNA Co. has a 52 week low of $163.02 and a 52 week high of $227.13.

CIGNA (NYSE:CI) last announced its quarterly earnings data on Thursday, November 1st. The health services provider reported $3.84 EPS for the quarter, topping the consensus estimate of $3.45 by $0.39. The business had revenue of $11.45 billion for the quarter, compared to analyst estimates of $11.19 billion. CIGNA had a net margin of 6.15% and a return on equity of 23.31%. The company’s revenue for the quarter was up 10.3% on a year-over-year basis. During the same quarter in the previous year, the firm posted $2.83 earnings per share. Research analysts predict that CIGNA Co. will post 14.35 earnings per share for the current year.

In other CIGNA news, insider Jason D. Sadler sold 21,189 shares of CIGNA stock in a transaction dated Friday, November 2nd. The shares were sold at an average price of $212.99, for a total value of $4,513,045.11. Following the sale, the insider now owns 41,966 shares of the company’s stock, valued at $8,938,338.34. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director William D. Zollars sold 238 shares of CIGNA stock in a transaction dated Friday, September 14th. The stock was sold at an average price of $193.70, for a total transaction of $46,100.60. The disclosure for this sale can be found here. In the last ninety days, insiders sold 24,252 shares of company stock worth $5,164,402. Insiders own 1.10% of the company’s stock.

TRADEMARK VIOLATION WARNING: This report was published by Chaffey Breeze and is owned by of Chaffey Breeze. If you are reading this report on another site, it was illegally stolen and republished in violation of US & international copyright & trademark law. The correct version of this report can be viewed at https://www.chaffeybreeze.com/2018/12/08/wealthsource-partners-llc-acquires-shares-of-980-cigna-co-ci.html.

About CIGNA

Cigna Corporation, a health services organization, provides insurance and related products and services in the United States and internationally. It operates through Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations segments. The Global Health Care segment offers medical, dental, behavioral health, vision, and prescription drug benefit plans, as well as health advocacy programs, and other products and services to insured and self-insured customers.

Featured Story: Return on Investment (ROI)

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CIGNA Co. (NYSE:CI).

Institutional Ownership by Quarter for CIGNA (NYSE:CI)

Receive News & Ratings for CIGNA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CIGNA and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply